The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Nonspecific Medication Side Effects and the Nocebo Phenomenon
Open accessAbstract
Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This discrepancy may be attributed to nonpharmacological processes, such as nocebo effects, due to the commonality of symptoms.”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [42]
In the citing paper
“Undue emphasis on discontinuation effects may increase the likelihood of real and debilitating symptoms, which arise (or are maintained) via processes distinct from pharmacological mechanisms (eg, nocebo effects).”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [42]
In the citing paper
“Similarly, there is evidence suggesting that negative expectations can contribute to a variety of side effects and adverse events in clinical trials and medical care (Amanzio et al., 2009; Barsky et al., 2002; Colloca and Finniss, 2012; Petersen et al., 2014).”
From Distinct neural representations of placebo and nocebo effects (2015) · cites this paper as Barsky et al., 2002
Citations
Cites
The Psychology of Physical Symptoms
Pennebaker, J. W. (1982) · Springer eBooks · doi:10.1007/978-1-4613-8196-9 · Cited by 1,789
BARSKY, A. J., & Borus, J. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00016 · Cited by 964
Self-citationDrug-related morbidity and mortality. A cost-of-illness model
Johnson, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.18.1949 · Cited by 942
The Importance of Placebo Effects in Pain Treatment and Research
Turner, J. A. (1994) · JAMA · doi:10.1001/jama.1994.03510440069036 · Cited by 871
The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly
Col, N. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390160093019 · Cited by 765
Drug-Related Hospital Admissions
Einarson, T. R. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700702 · Cited by 520
Adequacy and Duration of Antidepressant Treatment in Primary Care
Katon, W. J., Korff, M. V., Lin, E. H. B., Bush, T. M., & Ormel, J. (1992) · Medical Care · doi:10.1097/00005650-199201000-00007 · Cited by 519
Frequency and cost of serious adverse drug reactions in a department of general medicine
Moore, N. D., Lecointre, D., Noblet, C., & Mabille, M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00667.x · Cited by 322
Morphine Analgesic Tolerance: Its Situation Specificity Supports a Pavlovian Conditioning Model
Siegel, S. (1976) · Science · doi:10.1126/science.935870 · Cited by 318
Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness
de Craen, A. J. M., Roos, P., de Vries, A. L., & Kleijnen, J. (1996) · BMJ · doi:10.1136/bmj.313.7072.1624 · Cited by 313
Cited by
Sorted by citations
Items 701–783 of 783
Adverse Events Following a Medication Change: Psychological Contributors to a Health Scare
Faasse, K. (2012) · ResearchSpace (University of Auckland)
Placebo, Nocebo and no treatment
Grisold, W., & Grisold, S. (2018) · Revista de Fomento Social · doi:10.31190/rmn.2018.19.4.4.15
Placebo Analgesia as Nocebo Reduction
Fortunato, J. T., Wasserman, J. A., & Menkes, D. L. (2018) · AJOB Neuroscience · doi:10.1080/21507740.2018.1499682
Haven, K., & Balaban, C. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812344-7.00007-8
Placebos and Nocebos in Other Brain Disorders
Zis, P. (2019) · Headache · doi:10.1007/978-3-030-02976-0_9
Walker, M. (2013) · doi:10.1002/9781118357309.ch7
Patient-Centred Care in Headaches
Lampl, C., & Bräutigam, E. (2019) · Headache · doi:10.1007/978-3-030-02976-0_1
The next day effects of a normal night's drinking on cognition and human performance
Devenney, L. E. (2019) · Ulster University Research Portal (Ulster University)
Jones, K. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/yzz8-1487
L’effet nocebo dans la pratique courante
Agnihotri, K. (2020) · PubMed Central
Drugs and Family Medicine: Form and Content
Turabián, J. L. (2020) · Archives of Pharmacology and Therapeutics · doi:10.33696/pharmacol.2.015
Methods: Procedures for study implementation and protection of internal validity
Brondolo, E. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815680-3.00017-7
Refractory Gastroesophageal Reflux Disease: Surgical Perspective from a Multi-Disciplinary Practice
Grimsley, E. A., Meyer, L., & Velanovich, V. (2021) · Foregut The Journal of the American Foregut Society · doi:10.1177/26345161211021772
Szemerszky, R. (2011) · ELTE Digital Institutional Repository (EDIT) (Eötvös Loránd University)
Treatment Modalities of Burning Mouth Disease
van der Waal, I. (2021) · Springer eBooks · doi:10.1007/978-3-030-71640-0_8
A VOZ FEMININA NO JORNALISMO PAULISTA DO SÉCULO XIX: EM BUSCA DE UMA IDENTIDADE SOCIAL
Andrade, M. L. D. C. V. D. O. (2021) · doi:10.22533/at.ed.3142122111
SÍNDROME DE DOWN: IMPACTO NA FAMILIA, INCLUSÃO ESCOLA E SOCIEDADE
Moleta, E. T. S. (2021) · doi:10.22533/at.ed.3142122118
A ANÁLISE DE ERROS COMO METODOLOGIA DE ENSINO NAS AULAS DE MATEMÁTICA
Costa, J. R., & dos Santos, G. S. D. M. (2021) · doi:10.22533/at.ed.3142122114
Brito, M. S. D. O., Oliveira, N. P. B., & de Brito, M. P. (2021) · doi:10.22533/at.ed.3142122116
O MERCADO DE COSMÉTICOS NO BRASIL FRENTE A CRISE
Araujo, G. M. D. L. D. S. (2021) · doi:10.22533/at.ed.3142122115
DO BRANCO AO “BLANCO”: A APREENSÃO CORPORAL DAS LINGUAGENS POÉTICAS
Valeska, O., & de Araújo, S. P. (2021) · doi:10.22533/at.ed.3142122112
Rodríguez, M. M. (2021) · doi:10.22533/at.ed.3142122119 · Cited by 1
Studies Regarding Placebo and Nocebo Effect in Marketing
Guriță, D. (2021) · Anuarul Universitatii Petre Andrei din Iasi - Fascicula Drept Stiinte Economice Stiinte Politice · doi:10.18662/upalaw/75
Holbrook, A. M., Goldsmith, C. H., & Leung, M. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a04037
Holbrook, A. M., Goldsmith, C. H., & Leung, M. (2008) · Wiley Encyclopedia of Clinical Trials · doi:10.1002/9780471462422.eoct984
Holbrook, A. M., Goldsmith, C. H., & Leung, M. (2014) · doi:10.1002/9781118596005.ch61
Validating herbal therapeutics
(2013) · Elsevier eBooks · doi:10.1016/b978-0-443-06992-5.00004-9
Onghena, P. (2005) · Encyclopedia of Statistics in Behavioral Science · doi:10.1002/0470013192.bsa484
Moore, R. J., & Spiegel, D. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48007-7_1
(2018) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738017740913
Onghena, P. (2005) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat06679
Biosimilars und der Nocebo-Effekt
Braun, J., Tsiami, S., Buehring, B., KIEFER, D. M., Andreica, I., Baraliakos, X., & Kiltz, U. (2020) · rheuma plus · doi:10.1007/s12688-020-00366-y
Gebhart, G. F., & Schmidt, R. F. (2013) · Springer eBooks · doi:10.1007/978-3-642-28753-4_201447
(2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70332-1
Breidert, M. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0571
Benedetti, F. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198843177.003.0010
(2006) · Springer eBooks · doi:10.1007/978-3-540-29805-2_2738
Holbrook, A. M., Goldsmith, C. H., & Leung, M. (2005) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess7191
(2018) · V&R unipress eBooks · doi:10.14220/9783737009058.167
The treatment of behavior disorders in children with Benadryl
(2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.68
Karacaoglu, M., Peerdeman, K. J., Numans, M. E., Stolk, M., Meijer, S., Klinger, R., Veldhuijzen, D. S., van Middendorp, H., & Evers, A. W. M. (2022) · doi:10.31234/osf.io/de89n
Turabián, J. L. (2022) · MedPress Public Health and Epidemiolog · doi:10.33582/mpphe.2022.202210001
Rau, M., & Patel, S. (2020) · Archives of Ophthalmology and Optometry · doi:10.22259/2638-5120.0301004
Follow-Up of Side Effects throughout the Entire Course of Coronavirus Vaccination
Odeh, M. M., Al-Jussani, G. N., Ashour, A. A., AlNaqah, H., Hasan, H. A., Sbitan, L., Dawabsheh, A., & Alhawi, M. (2023) · Vaccines · doi:10.3390/vaccines11030704
Cigognini, M. A. (2023) · doi:10.11606/t.5.2023.tde-10052023-120550
Modalities and Dimensions of Interoception
Ferentzi, E. (2019) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2019.045
Nocebo og placebo – farmakoterapiens yin og yang
Wahl, A. (2023) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.23.0523
Psychiatric Models: Reconciling Neurobiology, Metaphor, and UncertaintyPreprint
Syed, A., & Jacob, M. (2023) · doi:10.31234/osf.io/ambse
Zaharia, S., & Horoșan, L. (2021) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2021.4.3
Memon, G. R., & Ali, M. A. I. (2019) · JMMC · doi:10.62118/jmmc.v8i2.35
Efecto placebo y efecto nocebo
Bourdin, V., & Mouly, S. J. (2025) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(24)49927-3
van Lennep, J. P. A., Meijer, S., Karacaoglu, M., Rippe, R. C. A., Peerdeman, K. J., van Middendorp, H., & Evers, A. W. M. (2025) · Pain Practice · doi:10.1111/papr.70000
Preventive, Therapeutic, and Palliative Care
Karhausen, L. (2025) · Philosophy and medicine · doi:10.1007/978-3-031-81257-6_14 · Cited by 1
Predicting the side effects of influenza vaccination
Silvester, C., Gasteiger, C., Gamble, G. D., Wilson, M., Faasse, K., Petrie, K. J., & MacKrill, K. (2025) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaf024
Allergy-like nocebo events reported with COVID-19 vaccines: a case control study
Brès, V., Fadhel, N. B., Trouillet, R., Broc, G., Chiriac, A. M., & Faillie, J. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2497397
Köteles, F. G. (2025) · Mentálhigiéné és Pszichoszomatika · doi:10.1556/0406.2024.00075
Wirkung ohne Wirkstoff – der Placebo-/Noceboeffekt
Likar, R., & Bernatzky, G. (2025) · Springer eBooks · doi:10.1007/978-3-662-68956-1_9
Sions, J. M., George, S. Z., Pugliese, J. M., Patterson, C. G., Piva, S. R., Simon, C. B., & Hicks, G. E. (2025) · Physical Therapy · doi:10.1093/ptj/pzaf124
Understanding the psychology of the nocebo effect
Rooney, T., & Colagiuri, B. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00005-4
When Are Medication Side Effects Due to the Nocebo Phenomenon?
Golomb, B. A. (2002) · JAMA · doi:10.1001/jama.287.19.2502-b
Cognitive bias modification for interpretation mitigates nocebo hyperalgesia
Rooney, T., Sharpe, L., Todd, J., & Colagiuri, B. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105646
Messner, K., Eickhoff, C., Schulz, M., Allemann, S. S., & Arnet, I. (2024) · Figshare · doi:10.6084/m9.figshare.24864265
Messner, K., Eickhoff, C., Schulz, M., Allemann, S. S., & Arnet, I. (2023) · Figshare · doi:10.6084/m9.figshare.24864157
When Are Medication Side Effects Due to the Nocebo Phenomenon?
Palmer, R. H. (2002) · JAMA · doi:10.1001/jama.287.19.2502-e
When Are Medication Side Effects Due to the Nocebo Phenomenon?
Caspi, O. (2002) · JAMA · doi:10.1001/jama.287.19.2502-a
When Are Medication Side Effects Due to the Nocebo Phenomenon?
Keeley, R. (2002) · JAMA · doi:10.1001/jama.287.19.2502-c
Trait Neuroticism and the Nocebo Effect: The Mediating Role of Side‐Effect Expectations
Fischer, A., Chuang, L.-C., Augustat, N., von Blanckenburg, P., & Mueller, E. M. (2026) · Journal of Personality · doi:10.1111/jopy.70056 · Cited by 1
Clemens, K. S. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1799549
What people want to know before surgery – The role of sex and expectation
Horn, N., Gärtner, L., Rief, W., & Salzmann, S. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109599
Nocebo effects in long-term health conditions: a systematic review of experimental studies
Church, B., Gupta, P., Shivaram, A., Jenkins, S., & Palmer, E. J. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1752434
Tairabune, T., Goto, T., Yamazaki, K., Kudo, K., Sako, K.-I., Maeda, T., & Chiba, T. (2026) · Pharmacy · doi:10.3390/pharmacy14030070
Minimizing nocebo side effects in health care: The unrecognized role of patient involvement.
Spotts, E. K., Tull, M., Faasse, K., & Geers, A. L. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109743
Self-reported antidepressant side effects in psychiatric patients with depressive disorders
von Knorring, J., Baryshnikov, I., Jylhä, P., Talaslahti, T., & Isometsä, E. (2026) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2026.2686197
Peng, S.-K., Tiao, P.-H., Chan, H., & Huang, Y. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109746 · Cited by 1
Pjetraj, D., Lionetti, E., Pulvirenti, A., Gesuita, R., & Catassi, C. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.06.014
Mindfulness and Informed Consent: Navigating Ethical Complexity Across Contexts
Berryman, K., Barclay, L., Hassed, C. S., & Hohwy, J. (2026) · Mindfulness · doi:10.1007/s12671-026-02939-y
Mijnster, R. J. M., Shaheen, N., Rietdijk, W. J. R., Martens, F. M. A. C., Bemelmans, R. H. H., Merkelbach, I., van der Kuy, P. H. M., Lafeber, M., & van Lennep, J. E. R. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag415
Coenen, M., Hartmann, G., & Büttner, T. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1913605
Interrogating side effects: The role of social information in treatment expectancies
Rooney, T., Tan, W., Sharpe, L., & Colagiuri, B. (2026) · Behaviour Research and Therapy · doi:10.1016/j.brat.2026.105167
Metadata
- Authors
- Barsky, A. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Barsky, Arthur J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-02-06
- Volume
- 287
- Issue
- 5
- Pages
- 622
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2030711540
- Cited by
- 784
- References
- 69
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 54 · 2021: 49 · 2020: 47 · 2019: 53 · 2018: 45 · 2017: 42 · 2016: 39 · 2015: 33 · 2014: 31 · 2013: 27 · 2012: 31
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- green
- dash.harvard.edu
- Licence
- cc-by
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- nocebo effect, adverse drug reactions, placebo effect, patient expectations, conditioning, anxiety, depression, somatization, patient-physician communication, risk factors
- MeSH terms
- Attitude to Health, Drug Therapy, Humans, Negativism, Placebos, Risk Factors, Effect Modifier, Epidemiologic, Placebo Effect, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review